Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Therapeutic Drug Monitoring
|
April 1, 1995
Stability of debrisoquine (CYP2D6) phenotype in liver transplant patients
A Bendriss, Y Bechtel, G Paintaud, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1995
Pharmacokinetics of a more reliable Chloraminophene formulation
C W Maboundou, J Magnette, G Paintaud, et al.
Therapie
|
January 25, 2002
Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses
F Odoul, C Le Guellec, C Giraut, et al.
Hepatology (Baltimore, Md.)
|
June 1, 1991
Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases
S Bresson-Hadni, A Franza, J P Miguet, et al.
Journal of Immunological Methods
|
July 27, 2007
Evaluation of a peptide ELISA for the detection of rituximab in serum
H Blasco, G Lalmanach, E Godat, et al.
Alimentary Pharmacology & Therapeutics
|
February 28, 2004
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease
E Louis, Z El Ghoul, S Vermeire, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 3, 2014
Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system
L Guilleminault, N Azzopardi, C Arnoult, et al.
Clinical and Experimental Immunology
|
December 6, 2013
Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study
B Chaigne, P Gatault, F Darrouzain, et al.
Annales Pharmaceutiques Francaises
|
December 15, 2007
[Molecular pharmacogenetics in hospital laboratories in France: current data and future prospects]
D Allorge, P-H Beaune, L Becquemont, et al.
Clinical and Experimental Immunology
|
May 12, 2015
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
B Rup, M Pallardy, D Sikkema, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Therapeutic Drug Monitoring
|
April 1, 1995
Stability of debrisoquine (CYP2D6) phenotype in liver transplant patients
A Bendriss, Y Bechtel, G Paintaud, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1995
Pharmacokinetics of a more reliable Chloraminophene formulation
C W Maboundou, J Magnette, G Paintaud, et al.
Therapie
|
January 25, 2002
Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses
F Odoul, C Le Guellec, C Giraut, et al.
Hepatology (Baltimore, Md.)
|
June 1, 1991
Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases
S Bresson-Hadni, A Franza, J P Miguet, et al.
Journal of Immunological Methods
|
July 27, 2007
Evaluation of a peptide ELISA for the detection of rituximab in serum
H Blasco, G Lalmanach, E Godat, et al.
Alimentary Pharmacology & Therapeutics
|
February 28, 2004
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease
E Louis, Z El Ghoul, S Vermeire, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 3, 2014
Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system
L Guilleminault, N Azzopardi, C Arnoult, et al.
Clinical and Experimental Immunology
|
December 6, 2013
Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study
B Chaigne, P Gatault, F Darrouzain, et al.
Annales Pharmaceutiques Francaises
|
December 15, 2007
[Molecular pharmacogenetics in hospital laboratories in France: current data and future prospects]
D Allorge, P-H Beaune, L Becquemont, et al.
Clinical and Experimental Immunology
|
May 12, 2015
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
B Rup, M Pallardy, D Sikkema, et al.
Page
of 7